Skip to main content
ConductScienceScienceDex

FY2024 NIH awards · Principal investigators

Pharmacology at UT MD Anderson Cancer Center

Houston, TX

Funding
$2.4M
$2,420,893
Awards
6
FY2024 NIH awards in Pharmacology
Principal investigators
3
3 lead a grant here, 0 co-investigators
Department rank
#81
of 139 · Ranking
  • NIH names only the principal investigators on an award, so this page lists only them. The department is the award's: it is where ScienceDex counts the award, not a list of the department's members.
  • These are the awards in the Pharmacology row of the UT MD Anderson Cancer Center page.

Leads a grant in this department

3 contact PIs of these awards, by the funding they lead. Other principal investigators on an award are listed with it and under Co-investigators.

  1. Rugang Zhang

    Leads 3 awards · $1,345,569

    • 5R01CA276569-02Department: NIH department code
      Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
      $495,433
      award amount
    • 5R01CA243142-05Department: NIH department code
      Regulation of tumor recurrence by stress activated neutrophils
      $489,730
      award amount
    • 5R01CA202919-09Department: NIH department code
      Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
      $360,406
      award amount

  2. Xi Chen

    Leads 2 awards · $844,917

    • 7R01CA270240-03Department: NIH department code
      Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
      $489,610
      award amount
    • 7R37CA228304-07Department: NIH department code
      Crosstalk Between the ER Stress Response and Mitochondrial Fatty Acid Oxidation in MYC-driven Breast Cancer
      $355,307
      award amount

  3. Simon Eschweiler

    Leads 1 award · $230,407

    • 5R37CA276779-03Department: NIH department code
      Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy
      $230,407
      award amount